RADMAB

Serial Number 79288877
Registration 6253802
700

Registration Progress

Application Filed
Mar 2, 2020
Under Examination
Approved for Publication
Nov 10, 2020
Published for Opposition
Nov 10, 2020
Registered
Jan 26, 2021

Trademark Image

RADMAB

Basic Information

Serial Number
79288877
Registration Number
6253802
Filing Date
March 2, 2020
Registration Date
January 26, 2021
Published for Opposition
November 10, 2020
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 26, 2021
Registration
Registered
Classes
005 010 042

Rights Holder

Telix Pharmaceuticals Limited

99
Address
Suite 401,
55 Flemington Road North Melbourne VIC
AU

Ownership History

Telix Pharmaceuticals Limited

Original Applicant
99
AU

Telix Pharmaceuticals Limited

Owner at Publication
99
AU

Telix Pharmaceuticals Limited

Original Registrant
99
AU

Legal Representation

Attorney
Andrew S. Ehard

USPTO Deadlines

Next Deadline
401 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20210126)
Due Date
January 26, 2027
Grace Period Ends
July 26, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Aug 14, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
May 23, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Apr 30, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 30, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Apr 26, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jan 26, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 10, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 10, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 21, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 1, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 27, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 22, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 21, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 21, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 5, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Aug 27, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 24, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jul 23, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 21, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 17, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 17, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 15, 2020 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Jul 2, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer; diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancer and also consisting of vials, needleless drug delivery devices, swabable vial adaptors and medical syringes; all of the foregoing containing monoclonal antibodies
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices for diagnostic radiopharmaceuticals; medical device for treating cancer; diagnostic imaging apparatus for medical use; applicators for pharmaceutical preparations, namely, drug delivery devices sold empty being syringes, infusion sets and catheters
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science all of the aforementioned in relation to radiopharmaceuticals and cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 010 042